Siop Europe, The European Society For Paediatric Oncology (siope)

What Siop Europe, The European Society For Paediatric Oncology (siope) does

SIOP Europe (SIOPE) is the European Society for Paediatric Oncology, a non-profit professional society founded in 1998 and headquartered in Vilvoorde, Belgium. The organisation functions as the pan-European umbrella body for paediatric oncology, coordinating national paediatric oncology societies, clinical trial groups, reference networks, patient and survivor organisations, and EU policy stakeholders. Its members and partners span clinicians, researchers, allied health professionals, regulators, and patient advocacy groups operating across European member states.

SIOPE's core deliverables centre on convening and knowledge production rather than commercial products. Its principal outputs include Standards of Care publications, position papers, the multi-year Strategic Plan (currently covering 2021-2026), and the operation of European Reference Networks such as ERN PaedCan. The organisation runs multi-stakeholder projects including MONALISA (launched 2025), which integrates digital decision support tools for clinical trial and care coordination, and participates in EU-funded consortia such as IMPACT-EU and ACCELERATE to accelerate paediatric oncology drug development. It also convenes policy events such as the European Parliament-hosted "No Child Left Behind" initiative to advance equitable access.

As a non-stock, non-profit entity, SIOPE is funded through a combination of membership dues from national societies and individual professionals, EU project grants, and partner contributions. It operates with a small staff (11-50 reported) and outsources much of its research and convening activity to specialised partner organisations, including CCRI for MONALISA coordination. Its competitive position rests on institutional recognition as the EU's primary interlocutor on paediatric oncology rather than on proprietary technology or commercial scale.

Name

Siop Europe, The European Society For Paediatric Oncology (siope)

Legal name

The European Society for Paediatric Oncology (SIOP Europe)

Website

https://siope.eu

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

SIOP Europe is a Belgian non-profit umbrella society, founded in 1998, coordinating European paediatric oncology clinicians, trial groups, reference networks, and patient organisations, and operating EU-funded projects such as MONALISA and IMPACT-EU.

Ownership category

akta.pro rank

Product category

Paediatric Oncology Professional Society

NAICS

Professional Organizations (813920), Other Individual and Family Services (624190), Other Similar Organizations (except Business, Professional, Labor, and Political Organizations) (81399)

SIC

Services-Membership Organizations (8600), Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL)

Keywords

• Paediatric oncology research
• Childhood cancer treatment
• Clinical trial coordination
• Oncology education programs
• Cancer care standards

Headquarters

HQ city

Brussels

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Distribution channels3 records

Marketing channels8 records

Core offering

SIOP Europe is a non-profit professional society that coordinates paediatric oncology research, education, and clinical standards of care across Europe. It brings together healthcare professionals, clinical trial groups, parent/patient organizations, and industry partners to advance the treatment of childhood cancers through pan-European collaboration, policy advocacy, and dissemination of best practices.

Product overview

SIOP Europe (The European Society for Paediatric Oncology) is a professional medical society rather than a traditional product company. The organization serves as the European branch of the International Society of Paediatric Oncology. Its offerings include scientific publications (European Journal of Paediatric Oncology), research initiatives (MONALISA Project, SIOPE CRC, European Clinical Trial Groups), professional education programs, advocacy initiatives (Standards of Care, European Strategic Plan 2021-2026), and networking through conferences (ACCELERATE Annual Conference, SIOP International). The society focuses on ensuring the best possible care and outcome for all children and young people with cancer through education, EU projects, policy strategy, and clinical research coordination.

Differentiator

Problem solved

Functional benefit

Products and services

• SIOPE Membership

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• MONALISA Project ConsortiumcoreStrategic or Co-development Partner · 1 January 2024The MONALISA project conducts pragmatic clinical trials evaluating liquid biopsies for monitoring relapsed neuroblastoma in children. Since May 2026, CCRI assumed project coordination while continuing scientific leadership with PMC. The project aims to establish liquid biopsies as standard-of-care for neuroblastoma monitoring.
• SIOPEN (European Society for Paediatric Oncology Network)coreStrategic or Co-development PartnerSIOPEN is a long-term collaborative network partner for SIOP Europe's projects, providing expertise in neuroblastoma research and pan-European clinical collaboration for paediatric oncology.
• St. Anna Children's Cancer Research Institute (CCRI)coreStrategic or Co-development PartnerCCRI serves as project coordinator and provides scientific leadership for the MONALISA project alongside SIOP Europe. CCRI leads the pragmatic clinical trial evaluating liquid biopsies for neuroblastoma monitoring.
• Princess Máxima Center (PMC) for Pediatric OncologycoreStrategic or Co-development PartnerPrincess Máxima Center serves as a lead partner in the MONALISA project for paediatric oncology, providing scientific leadership alongside CCRI and coordinating clinical trial activities.
• ERN PaedCan (European Reference Network for Paediatric Cancer)coreStrategic or Co-development PartnerERN PaedCan is a key project partner working on European reference network development for paediatric cancer, with news releases and collaborative activities with SIOP Europe.
• ACCELERATE PlatformminorStrategic or Co-development PartnerACCELERATE is a collaborative platform for paediatric oncology. SIOP Europe co-hosts the ACCELERATE Annual Conference focusing on advancing paediatric oncology research and drug development.
• PARTNER ProjectminorStrategic or Co-development PartnerPARTNER is a collaborative EU project working with SIOP Europe on initiatives related to paediatric oncology research and patient care across Europe.
• PanCareminorStrategic or Co-development PartnerPanCare is a European platform for survivors of childhood and adolescent cancer. SIOP Europe collaborates with PanCare on survivorship care and late effects research.

Recent moves6 records

Expansion highlights4 records

Others

• International Agency for Research on Cancer (IARC): The WHO's specialised cancer research agency. IARC is comparable as a coordinating body for cancer research globally and an ecosystem participant relevant to SIOPE's research standards and epidemiological work.
• European Society for Paediatric Research (ESPR): A European society advancing paediatric research broadly (not just oncology). ESPR is thematically adjacent and a potential collaboration partner for SIOPE on cross-cutting paediatric research initiatives.
• St. Anna Children's Cancer Research Institute (CCRI): An Austrian research institute and SIOPE's core partner coordinating the MONALISA project. While an operational research institution rather than a society, CCRI is directly intertwined with SIOPE's flagship clinical trial activity.
• European Hematology Association (EHA): The European professional society for haematology. EHA is thematically adjacent through SIOPE's work on haematological paediatric cancers and has co-organised focused symposia with SIOP Europe.

Broad incumbents

• European Cancer Organisation (ECO): A pan-European umbrella cancer organisation that influences EU cancer policy. ECO is comparable as a higher-level oncology coordination body and a potential competitor for EU policy attention and funding.
• European Society for Medical Oncology (ESMO): The dominant European professional society for medical oncology. While broader in scope (adult and paediatric), ESMO is a co-organiser of focused symposia with SIOPE and represents the larger incumbent context in which paediatric oncology operates.

Direct peers

• Children's Oncology Group (COG): The largest paediatric cancer clinical trials group in North America, operating similarly to SIOPE's European Clinical Trial Groups. Directly comparable in coordinating multi-site paediatric oncology clinical research, though geographically focused on the US/Canada.
• SIOP (International Society of Paediatric Oncology): The global parent organisation of SIOP Europe; both are medical societies focused on paediatric oncology, sharing mission, governance patterns, and events (e.g., SIOP 2026). They are structurally aligned, with SIOP Europe being the European continental branch.
• International Confederation of Childhood Cancer Parent Organisations (ICCCPO): A global parent/patient umbrella organisation for childhood cancer, paralleling SIOP Europe's role but on the patient/family side. They frequently partner on advocacy and information dissemination for paediatric oncology.

Regional players

• American Society of Pediatric Hematology/Oncology (ASPHO): The US professional society for paediatric haematology/oncology, structurally analogous to SIOP Europe but serving North America. Comparable in mission, education, and standards-setting, though operating in a different regulatory and clinical environment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/SIOPEurope
• YouTubeyoutube.com/results?search_query=siope+europe
• Facebookfacebook.com/p/SIOP-Europe-the-European-Society-for-Paediatric-Oncology-SIOPE-100064920005069
• LinkedInlinkedin.com/company/siope---european-society-for-paediatric-oncology
• Instagraminstagram.com/siopeurope

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Siop Europe, The European Society For Paediatric Oncology (siope)